Zobrazeno 1 - 10
of 11
pro vyhledávání: ''
Autor:
Seock-Ah Im, Jee Hyun Kim, Jin-Young Jang, Do-Youn Oh, Sae-Won Han, Yung-Jue Bang, Sung W. Ha, Sun Whe Kim, Jihyun Kwon, Eui Kyu Chie, Jae Sung Kim, Tae-You Kim, Kyung-Hun Lee
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose Despite curative resection, the 5-year survival for patients with resectable pancreatic cancer is less than 20%. Recurrence occurs both locally and at distant sites and effective multimodality adjuvant treatment is needed.Materials and Method
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose There are unmet needs associated with the current treatment strategies for relapsed/refractory diffuse large B-cell lymphoma (DLBCL) due to the poor treatment outcomes of these strategies. Roflumilast, a selective phosphodiesterase-4 inhibito
Autor:
Heung-Moon Chang, Jae Ho Jeong, Kyo-Pyo Kim, Bum Jun Kim, Baek-Yeol Ryoo, Changhoon Yoo, Jaewon Hyung
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose Gemcitabine plus cisplatin (GemCis) is the standard first-line chemotherapy for patients with advanced biliary tract cancer (BTC). In ABC-02 study, the BTC patients received up to 6-8 cycles of 3-weekly GemCis; however, those without progress
Autor:
Eun Joo Kang, Sun Min Lim, Yoon Ho Ko, Joo Hang Kim, Sangwoo Kim, Byoung Chul Cho, Hee Kyung Ahn, Hyun Chang, Dongmin Jung, Byung-Ho Nam, Keun-Wook Lee, Hye Ryun Kim, Jung Hye Kwon, Ji Eun Kim, Sang-Hee Cho, In Gyu Hwang, Myung-Ju Ahn, Keon Uk Park, Ji Hyung Hong, Sang Hoon Chun, Hwan Jung Yun, Jae Woo Choi, Tak Yun, Min Kyoung Kim, Jong Gwon Choi, Hyun Woo Lee, Ji Won Kim, Bhumsuk Keam, Jin-Soo Kim
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose Head and neck squamous cell carcinoma (HNSCC) is a deadly disease in which precision medicine needs to be incorporated. We aimed to implement next-generation sequencing (NGS) in determining actionable targets to guide appropriate molecular ta
Autor:
Seok Yun Kang, Dae Young Zang, Ki Hyang Kim, Hyo Song Kim, Minkyu Jung, Kyung Hee Lee, Inkyung Jung, Moon Hee Lee, Sung Hoon Noh, Bong Seog Kim, Dong Bok Shin, Woo Jin Hyung, Jae Ho Cheong, Sun Young Rha, Hyun Cheol Chung, Choong-kun Lee
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose We conducted a randomized, multicenter, phase III trial to compare S-1 plus docetaxel (DS) with S-1 plus cisplatin (SP) as adjuvant chemotherapy for stage III gastric cancer patients. Materials and Methods Stage III gastric cancer patients wh
Autor:
Eun Kyung Cho, Keunchil Park, Mauro Orlando, Maximino Bello, Tarun Puri, H. Depenbrock, Sumitra Thongprasert, Victoria Soldatenkova, Eun-Kee Song, Myung-Ju Ahn
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose The phase 3 randomized SQUIRE study revealed significantly longer overall survival (OS) and progression-free survival (PFS) for necitumumab plus gemcitabine and cisplatin (neci+GC) than for gemcitabine and cisplatin alone (GC) in 1,093 patien
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose We evaluated the clinical utility of excision repair cross-complementation group 1 (ERCC1) expression as a predictive biomarker for platinum-based chemotherapy in advanced non-small cell lung cancer (NSCLC). Materials and methods Eligible pat
Autor:
Jin Won Kim, Bum Jun Kim, Sook Ryun Park, Hye Sook Han, Mi-Jung Kim, Young Iee Park, Keun-Wook Lee
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose This study evaluated the re-challenge of S-1 or cisplatin in combination with docetaxel in metastatic gastric cancer (MGC) that had progressed on a cisplatin plus either S-1 or capecitabine regimen. Materials and Methods Patients with progres
Autor:
Stephen M. Keefe, Ronac Mamtani, David J. Vaughn, S. Bruce Malkowicz, Vivek Narayan, Thomas J. Guzzo
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose We sought to investigate the safety and efficacy of gemcitabine, cisplatin, and lapatinib (GCL) as neoadjuvant therapy in patients with muscle-invasive bladder cancer (MIBC) planned for radical cystectomy. Materials and Methods Four cycles of
Autor:
Ji Hye Cha, Jee Suk Chang, Kyung Hwan Kim, Ik Jae Lee, Chang Geol Lee, Kyung Ran Park, Byoung Chul Cho, Dae Joon Kim
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
PURPOSE The purpose of this study was to evaluate the benefits of adjuvant treatment for curatively resected thoracic esophageal squamous cell carcinoma (ESCC) and determine the optimal adjuvant treatments. MATERIALS AND METHODS One hundred ninety-fi